What is Psoriasis?
Psoriasis is an inflammatory skin condition that involves red elevated patches and flaking silvery scales. Psoriasis can be painful and itchy with dry, flaky, inflamed skin. It is most commonly found on the elbows, knees, scalp, chest, and lower back. It is thought to be caused by a malfunctioning immune system where white blood cells are triggered, causing inflammation and skin cells to shed at an abnormally quick rate.
- Topical corticosteroids
- Topical derivatives of vitamin D (calcitriol and calcipotriol)
- Topical derivatives of vitamin A (tazarotene)
- Coal tar
- Light therapy
- Biologics (alefacept, etanercept, adalimumab, infliximab, ustekinumab)
We currently do not have any recruiting clinical trials for psoriasis. Please contact us to be placed on a contact list for our next available clinical trial.
An Evaluator-Blinded Safety and Efficacy Study of GSK2894512 versus Vehicle and versus Calcipotriene in the Treatment of Adult Plaque Psoriasis. A Long-Term, Open-Label, Extension Study to Evaluate the Safety and Efficacy of GSK2894512 Cream for the Treatment of Plaque Psoriasis
- Age 18 years and over
- Mild, moderate, or severe plaque psoriasis
- 12 weeks of treatment with topical medication or placebo with possible extension to receive medication for 40 additional weeks
- Approximately 8 clinic visits over a period of about 17 weeks with extension adding approximately 8 clinic visits over a period of 41 weeks